Molecular Partners AG
MOLN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $5 | $7 | $190 | $9 |
| % Growth | -29.4% | -96.3% | 1,931.7% | – |
| Cost of Goods Sold | $48 | $48 | $51 | $56 |
| Gross Profit | -$43 | -$41 | $139 | -$46 |
| % Margin | -855.8% | -579.8% | 73.2% | -497.2% |
| R&D Expenses | $49 | $49 | $51 | $56 |
| G&A Expenses | $17 | $19 | $22 | $17 |
| SG&A Expenses | $17 | $19 | $22 | $17 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$47 | -$47 | $0 | $0 |
| Operating Expenses | $19 | $20 | $73 | $73 |
| Operating Income | -$61 | -$61 | $117 | -$63 |
| % Margin | -1,231.7% | -868.3% | 61.5% | -679.7% |
| Other Income/Exp. Net | $7 | -$1 | $1 | -$0 |
| Pre-Tax Income | -$54 | -$62 | $118 | -$64 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$54 | -$62 | $118 | -$64 |
| % Margin | -1,087.4% | -880.7% | 62.2% | -683.7% |
| EPS | -1.59 | -1.89 | 3.63 | -2.06 |
| % Growth | 15.9% | -152.1% | 276.2% | – |
| EPS Diluted | -1.59 | -1.89 | 3.54 | -2.06 |
| Weighted Avg Shares Out | 34 | 33 | 32 | 31 |
| Weighted Avg Shares Out Dil | 34 | 33 | 33 | 31 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3 | $4 | $1 | $0 |
| Interest Expense | $0 | $0 | $1 | $1 |
| Depreciation & Amortization | $2 | $2 | $2 | $3 |
| EBITDA | -$52 | -$60 | $119 | -$61 |
| % Margin | -1,039.2% | -845.6% | 62.8% | -650.2% |